Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

Potential biomarker discovered for brain tumors in children

researcher in lab © Medical University of Vienna/Houdek

This was shown by a study conducted at the Medical University of Vienna (MedUni Vienna) and Vienna General Hospital within the framework of the Comprehensive Cancer Center (CCC) and in collaboration with the German Cancer Research Center in Heidelberg.

The new study by Johannes Gojo, junior doctor and researcher at the Department of Pediatrics and Adolescent Medicine of MedUni Vienna and Vienna General Hospital and member of the CCC, investigated whether the enzyme telomerase could be used as a biomarker for ependymomas. Gojo states: "We were able to show that telomerase was primarily reactivated in tumors that exhibit a particularly aggressive course. This means that the tumor recurred despite surgical removal and subsequent radiotherapy and chemotherapy." The scientists suspect that this will enable them to identify patients who would benefit from more intensive treatment. Conversely, patients with less aggressive tumors could be spared chemotherapy. This would mean a huge improvement in the quality of life for those affected. "Together with other parameters, the presence of telomerase could be a big help in deciding on the course of treatment. It therefore represents a highly promising biomarker.” The study was published in the leading scientific journal Nero-Oncology.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • 17. Mittelstandstag FrankfurtRheinMain

    07.11.2019, Frankfurt on the Main, Germany

  • MEDICA 2019

    18.11.- 21.11. 2019, Dusseldorf, Germany, Germany

Austria Map

Find the perfect location for your company

A country like Austria considered to be an especially good terrain for upscale industrial segments, and with a particular emphasis on research and environmental friendliness, represents a major opportunity for SIAD. Our corporate goal is namely to assist the customer and provide support in improving the productivity and the environmental compatibility of its work processes.

SIAD

SIAD
More testimonials

news from the business location Austria

Siemens: New robot welding plant in Graz

Siemens Mobility has put a new robot-controlled frame welding facility into operation in Graz.

Coming back for seconds: Why big brands expand their (R&D) presence in Austria

The high-tech multinational Infineon is investing more than EUR 1.6 billion to expand its main facility in Austria. The pharmaceutical company Octapharma is massively expanding its Vienna-based operations at a cost of EUR 142 million. Headlines like these have recently caused people to sit up and take notice. But the question is: why is Austria as a research location so popular with international firms which are already established here?

More news All blog posts